Stratos Wealth Advisors LLC Has $559,000 Holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Stratos Wealth Advisors LLC lifted its stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 140.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,500 shares of the company’s stock after acquiring an additional 4,963 shares during the period. Stratos Wealth Advisors LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $559,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Allworth Financial LP lifted its position in iShares U.S. Pharmaceuticals ETF by 9.4% in the third quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock worth $131,000 after purchasing an additional 159 shares during the period. Assetmark Inc. lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% during the 3rd quarter. Assetmark Inc. now owns 432 shares of the company’s stock worth $31,000 after acquiring an additional 216 shares during the period. US Bancorp DE boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 137.0% during the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after acquiring an additional 222 shares in the last quarter. Janney Montgomery Scott LLC increased its stake in iShares U.S. Pharmaceuticals ETF by 4.1% in the fourth quarter. Janney Montgomery Scott LLC now owns 6,699 shares of the company’s stock valued at $440,000 after acquiring an additional 261 shares during the period. Finally, Wealth Enhancement Advisory Services LLC raised its position in iShares U.S. Pharmaceuticals ETF by 11.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock worth $253,000 after purchasing an additional 356 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Down 0.5 %

NYSEARCA IHE opened at $70.05 on Friday. iShares U.S. Pharmaceuticals ETF has a 1-year low of $62.67 and a 1-year high of $72.94. The company has a market capitalization of $707.51 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. The stock’s 50 day moving average is $67.35 and its two-hundred day moving average is $69.09.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.